Advisor Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$256K Buy
1,577
+344
+28% +$54.4K 0.02% 695
2022
Q1
$232K Buy
1,233
+138
+13% +$26.2K 0.01% 764
2021
Q4
$290K Buy
1,095
+83
+8% +$22.4K 0.02% 677
2021
Q3
$292K Sell
1,012
-51
-5% -$13.1K 0.02% 653
2021
Q2
$212K Sell
1,063
-52
-5% -$10.1K 0.01% 780
2021
Q1
$217K Sell
1,115
-1
-0.1% -$205 0.02% 745
2020
Q4
$214K Buy
+1,116
New +$203K 0.02% 687

Other funds holding RGEN

Advisor Partners's RGEN Position: Q2 2022 in Review

Advisor Partners increased its Repligen (RGEN) stake by 28% in Q2 2022, buying an estimated $54.4K and bringing the position to 1,577 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #695.

Advisor Partners first reported a position in RGEN in Q4 2020 and has held it in 7 quarters since. The position peaked at $292K in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Advisor Partners held 1,577 shares of Repligen worth $256K as of Q2 2022.
  • Advisor Partners bought 344 Repligen shares in Q2 2022, an estimated $54.4K.
  • Repligen made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #695 holding.
  • Advisor Partners first reported a position in Repligen in Q4 2020 and has held it in 7 quarters since.
  • Advisor Partners's Repligen position peaked at $292K in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.